Application of activity-based protein profiling to the study of microbial pathogenesis

Topics in Current Chemistry

Volumn 324, Issue , 2012, Pages 115-135

  Heal, William P ^a   Tate, Edward W ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Activity based probes; Activity based protein profiling; Antibiotic resistance; Catalomics; Clostridium difficile; Host pathogen interactions; Infectious disease; Malaria; MRSA; Pathogens; Virulence factors

Indexed keywords

PROTEIN;

BACTERIUM; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; METHODOLOGY; PATHOGENICITY; PROTEIN MICROARRAY; PROTEOMICS; QUORUM SENSING; REVIEW;

BACTERIA; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; QUORUM SENSING;

EID: 84857768953     PISSN: 03401022     EISSN: None     Source Type: Book Series    
DOI: 10.1007/128_2011_299     Document Type: Review

References (41)

1. World Health Organization (2011) WHO, Geneva. http://www.euro.who.int/en/ home
2. Staub I, Sieber SA (2009) Beta-lactam probes as selective chemical-proteomic tools for the identification and functional characterization of resistance associated enzymes in MRSA. J Am Chem Soc 131:6271
3. Heal WP, Dang TH, Tate EW (2011) Activity-based probes: discovering new biology and new drug targets. Chem Soc Rev 40:246
4. Heal WP, Wickramasinghe SR, Tate EW (2008) Activity based chemical proteomics: profiling proteases as drug targets. Curr Drug Discov Technol 5:200
5. Tang C, Holden D (1999) Pathogen virulence genes-implications for vaccines and drug therapy. Br Med Bull 55:387
6. Miller MB, Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol 55:165
7. Masuda K, Itoh M, Kawata T (1989) Characterization and reassembly of a regular array in the cell wall of Clostridium difficile GAI 4131. Microbiol Immunol 33:287
8. Sleytr UB, Messner P (1983) Crystalline surface layers on bacteria. Annu Rev Microbiol 37:311
9. Dang TH, de la Riva L, Fagan RP, Storck EM, Heal WP, Janoir C, Fairweather NF, Tate EW (2010) Chemical probes of surface layer biogenesis in Clostridium difficile. ACS Chem Biol 5:279
10. Schirmeister T, Klockow A (2003) Cysteine protease inhibitors containing small rings. Mini Rev Med Chem 3:585
11. Bottcher T, Sieber SA (2010) Showdomycin as a versatile chemical tool for the detection of pathogenesis-associated enzymes in bacteria. J Am Chem Soc 132:6964
12. Uehara Y, Fisher JM, Rabinovitz M (1980) Showdomycin and its reactive moiety, maleimide. A comparison in selective toxicity and mechanism of action in vitro. Biochem Pharmacol 29:2199
13. Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526
14. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176
15. Puri AW, Lupardus PJ, Deu E, Albrow VE, Garcia KC, Bogyo M, Shen A (2010) Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem Biol 17:1201
16. Shen A, Lupardus PJ, Albrow VE, Guzzetta A, Powers JC, Garcia KC, Bogyo M (2009) Mechanistic and structural insights into the proteolytic activation of Vibrio cholerae MARTX toxin. Nat Chem Biol 5:469
17. Greenbaum D, Medzihradszky KF, Burlingame A, Bogyo M (2000) Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem Biol 7:569
18. Bogyo M, Verhelst S, Bellingard-Dubouchaud V, Toba S, Greenbaum D (2000) Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs. Chem Biol 7:27
19. Shen A, Lupardus PJ, Gersch MM, Puri AW, Albrow VE, Garcia KC, Bogyo M (2011) Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nat Struct Mol Biol 18:364
20. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505
21. Bottcher T, Sieber SA (2008) Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angew Chem Int Ed Engl 47:4600
22. Bottcher T, Sieber SA (2008) Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. J Am Chem Soc 130:14400
23. Frees D, Qazi SN, Hill PJ, Ingmer H (2003) Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 48:1565
24. Staudinger H (1907) Zur Kenntniss der Ketene. Diphenylketen. Justus Liebigs Ann Chem 356:51
25. Chain E, Florey HW, Gardner AD, Heatley NG, Jennings MA, Orr-Ewing J, Sanders AG (1940) Penicillin as a chemotherapoutic agent. Lancet 236:226
26. Abraham EP, Chain E (1940) An enzyme from bacteria able to destroy penicillin. Nature 46:837
27. Breman JG (2001) The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 64:1
28. Greenbaum DC, Baruch A, Grainger M, Bozdech Z, Medzihradszky KF, Engel J, DeRisi J, Holder AA, Bogyo M (2002) A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298:2002
29. Hastings JW, Nealson KH (1977) Bacterial bioluminescence. Annu Rev Microbiol 31:549
30. Engebrecht J, Nealson K, Silverman M (1983) Bacterial bioluminescence: isolation and genetic analysis of functions from Vibrio fischeri. Cell 32:773
31. Chan KG, Atkinson S, Mathee K, Sam CK, Chhabra SR, Camara M, Koh CL, Williams P (2011) Characterization of N-acylhomoserine lactone-degrading bacteria associated with the Zingiber officinale (ginger) rhizosphere: co-existence of quorum quenching and quorum sensing in Acinetobacter and Burkholderia. BMC Microbiol 11:51
32. Ritchie AJ, Jansson A, Stallberg J, Nilsson P, Lysaght P, Cooley MA (2005) The Pseudomonas aeruginosa quorum-sensing molecule N-3-(oxododecanoyl)-L- homoserine lactone inhibits Tcell differentiation and cytokine production by a mechanism involving an early step in T-cell activation. Infect Immun 73:1648
33. Kravchenko VV, Kaufmann GF, Mathison JC, Scott DA, Katz AZ, Grauer DC, Lehmann M, Meijler MM, Janda KD, Ulevitch RJ (2008) Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule. Science 321:259
34. Dubinsky L, Jarosz LM, Amara N, Krief P, Kravchenko VV, Krom BP, Meijler MM (2009) Synthesis and validation of a probe to identify quorum sensing receptors. Chem Commun 47:7378
35. Blencowe A, Hayes W (2005) Development and application of diazirines in biological and synthetic macromolecular systems. Soft Matter 1:178
36. Winson MK, Swift S, Fish L, Throup JP, Jorgensen F, Chhabra SR, Bycroft BW, Williams P, Stewart GS (1998) Construction and analysis of luxCDABE-based plasmid sensors for investigating N-acyl homoserine lactone-mediated quorum sensing. FEMS Microbiol Lett 163:185
37. Rayo J, Amara N, Krief P, Meijler MM (2011) Live cell labeling of native intracellular bacterial receptors using aniline-catalyzed oxime ligation. J Am Chem Soc 133:7469
38. Amara N, Mashiach R, Amar D, Krief P, Spieser SA, Bottomley MJ, Aharoni A, Meijler MM (2009) Covalent inhibition of bacterial quorum sensing. J Am Chem Soc 131:10610
39. Garner AL, Yu J, Struss AK, Lowery CA, Zhu J, Kim SK, Park J, Mayorov AV, Kaufmann GF, Kravchenko VV, Janda KD (2011) Synthesis of 'clickable' acylhomoserine lactone quorum sensing probes: unanticipated effects on mammalian cell activation. Bioorg Med Chem Lett 21:2702
40. Dirksen A, Hackeng TM, Dawson PE (2006) Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl 45:7581
41. Ventre I, Ledgham F, Prima V, Lazdunski A, Foglino M, Sturgis JN (2003) Dimerization of the quorum sensing regulator RhlR: development of a method using EGFP fluorescence anisotropy. Mol Microbiol 48:187